Proteomics International Laboratories Ltd. announced the appointments of Robyn Elliott and Neville Gardiner to its Board as independent, non-executive Directors, effective 16 November 2021. Mr. Gardiner was recently a Partner of Deloitte in its M&A Advisory team. He is a seasoned finance professional with over 30 years' experience advising Boards of public and private companies on mergers and acquisitions, project development, equity and debt capital markets, transaction structuring, capital allocation and complex commercial problem solving. Dr. Elliott is Executive Director, Strategic Fractionation Program Delivery within the Global Network Strategy team CSL Behring. Her role is responsible for business value delivery from a billion dollar global capital expansion portfolio. She is also non-executive Director of PolyNovo Limited. Dr. Elliott's 9 years at CSL Behring have included Senior Director roles for Strategic Expansion Projects and Quality, including supporting the global network strategy team determining the ten-year expansion plan for the CSL Behring global business.